|
Federal
Register Notices > Notice
of Registration - 2005 > Mallinckrodt Inc
FR Doc 05-16288 [Federal Register: August 17, 2005 (Volume 70,
Number 158)] [Notices] [Page 48441] From the Federal Register Online
via GPO Access [wais.access.gpo.gov] [DOCID:fr17au05-107]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated March 25, 2005, and published in the Federal
Register on April 4, 2005 (70 FR 17124-17125), Mallinckrodt Inc., 3600
North Second Street, St. Louis, Missouri 63147, made application by
renewal to the Drug Enforcement Administration (DEA) to be registered
as a bulk manufacturer of the basic classes of controlled substances
listed in Schedules I and II:
| Drug |
Schedule |
| Tetrahydrocannabinols (7370) |
|
| Codeine-N-oxide (9053) |
I |
| Dihydromorphine (9145) |
I |
| Difenoxin (9168) |
I |
| Morphine-N-oxide (9307) |
I |
| Normorphine (9313) |
I |
| Norlevorphanol (9634) |
I |
| Amphetamine (1100) |
II |
| Methamphetamine (1105) |
II |
| Methylphenidate (1724) |
II |
| Codeine (9050) |
II |
| Diprenorphine (9058) |
II |
| Etorphine HCL (9059) |
II |
| Dihydrocodeine (9120) |
II |
| Hydromorphone (9150) |
II |
| Oxycodone (9143) |
II |
| Diphenoxylate (9170) |
II |
| Benzoylecgonine (9180) |
II |
| Hydrocodone (9193) |
II |
| Levorphanol (9220) |
II |
| Meperidine (9230) |
II |
| Methadone (9250) |
II |
| Methadone Intermediate (9254) |
II |
| Metopon (9260) |
II |
| Dextropropoxyphene (9273) |
II |
| Morphine (9300) |
II |
| Thebaine (9333) |
II |
| Opium extracts (9610) |
II |
| Opium fluid extract (9620) |
II |
| Opium tincture (9630) |
II |
| Opium, powdered (9639) |
II |
| Opium, granulated (9640) |
II |
| Levo-alphacetylmethadol (9648) |
II |
| Oxymorphone (9652) |
II |
| Noroxymorphone (9668) |
II |
| Alfentanil (9737) |
II |
| Remifentanil (9739) |
II |
| Sufentanil (9740) |
II |
| Fentanyl (9801) |
II |
The company plans to manufacture the listed controlled substances
for internal use and for distribution to its customers.
No comments or objections have been received. DEA has considered
the factors in 21
U.S.C. 823(a) and determined that the registration
of Mallinckrodt Inc. to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this
time. DEA has investigated Mallinckrodt Inc. to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background
and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance
with 21 CFR
1301.33, the above named company is granted registration
as a bulk manufacturer of the basic classes of controlled substances
listed.
Dated: August 11, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control,
Drug Enforcement Administration.
[FR Doc. 05-16288 Filed 8-16-05; 8:45 am]
BILLING CODE 4410-09-U
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|